barcelona . spain - European Association for the Study of the Liver

BARCELONA . SPAIN
124 POSTGRADUATE COURSE SYLLABUS ALCOHOLIC LIVER DISEASE 125
APRIL 18 - 19/2012 THE INTERNATIONAL LIVER CONGRESS TM 2012
REFERENCES:
Singal AK, Anand BS Mechanisms of synergy between alcohol and hepatitis C virus
J Clin Gastroenterol 2007;41:761-72.
Wang Y, Seitz H, Wang X. Moderate alcohol consumption aggravates high-fat
diet induced steatohepatitis in rats. Alcoholism: Clinical and Experimental Research 2010;
34:567-73.
Ioannou GN, Weiss NS, Kowdley KV. Relationship between transferrin-iron saturation,
alcohol consumption, and the incidence of cirrhosis and liver cancer. Clin Gastroenterol
Hepatol 2007;5:624-9.
Seitz HK, Mueller S. Alcohol metabolism and its consequences. In in press
Wang XD, Seitz HK. Alcohol and retinois interaction. In: Watson RR, Preedy VR (eds)
Nutrition and Alcohol:Linking nutrient interactions and dietary intake. CRC Press Boca
Raton, London, New York, Washington. Pp 313-21.
Pessione F, Degos F, Marcellin P, Duchatelle V, Njapoum C, Martinot-Peignoux M, Degott C,
Valla D, Erlinger S, Rueff B. Effect of alcohol consumption on serum hepatitis C virus RNA
and histological lesions in chronic hepatitis C. Hepatology. 1998;27:1717–1722.
Cromie SL, Jenkins PJ, Bowden DS, Dudley FJ. Chronic hepatitis C: effect of alcohol
on hepatitic activity and viral titre. J Hepatol. 1996;25:821–826.
Mueller S, Millonig G, Seitz HK. Alcoholic liver disease and hepatitis C: a frequently
underestimated combination. World J Gastroenterol 2009;15:3462-71
Wiley TE, McCarthy M, Breidi L, McCarthy M, Layden TJ. Impact of alcohol on the histological
and clinical progression of hepatitis C infection. Hepatology. 1998;28:805–809.
Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with
chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.
Lancet. 1997;349:825–832.
Westin J, Lagging M, Spak F, Aires N, Svensson E, Lindh M, Dhillon AP, Norkrans G,
Wejstal R. Moderate alcohol intake increases fibrosis progession in untreated patients with
hepatitis C virus infection J Virol Hepat 2002;9:235-41.
Tagger A, Donato F, Ribero ML, Chiesa R, Portera G, Gelatti U, Albertini A, Fasola M,
Boffetta P, Nardi G. Case-control study on hepatitis C virus (HCV) as a risk factor for
hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus
and alcohol. Brescia HCC Study. Int J Cancer 1999;81:695-9.
Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ.
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis
and diabetes mellitus. Hepatology 2002;36:1206-13.
Anand BS, Currie S, Dieperink E, Bini EJ, Shen H, Ho SB, Wright T, VA-HCV-001
Study Group. Alcohol use and treatment of hepatitis C virus: results of a national multicenter
study. Gastroenetrology 2006;130:1607-16.
Ohnishi K, Iida S, Iwama S, Goto N, Nomura F, Takashi M, Mishima A, Kono K, Kimura K,
Musha H, Kotota K, Okuda K. The effect of chronic habitual alcohol intake on the development
of liver cirrhosis and hepatocellular carcinoma: relation to hepatitis B surface antigen carriage.
Cancer 1982;49:672-7
Greenfield JR, Samaras K, Hayward CS, Chisholm DJ, Campbell LV. Beneficial postprandial
effect of a small amount of alcohol on diabetes and cardiovascular risk factors: modification
by insulin resistance. J Clin Endocrin Metab 2005;90:661-72.
Bellentani S, Tiribelli C. The spectrum of liver disease in the general population: lesson from
the Dionysos study. J Hepatol 2001; 35:531-7.
Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor
for alcoholic liver disease. Hepatology 1997;25:108-11.
Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC, Naveau S. Risk factors of
Figure 1
fibrosis in alcohol-induced liver disease. Hepatology 2002;35:635-8
Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence
and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
Hepatology 2010;51:1972-8.
Wang Y, Millonig G, Nair J, Patsenker E, Stickel F, Mueller S, Bartsch H, Seitz HK.
Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic
liver disease. Hepatology 2009;50:453-61.
Huang YS, Chern HD, Su WJ, Wu JC, Chang SC, Chiang CH, Chang FY, Lee SD. Cytochrome
P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis.
Hepatology 2003;37:924-30
Wang XD, Liu C, Chung J, Stickel F, Seitz HK, Russell RM. Chronic alcohol intake reduces
retinoic acid concentration and enhances AP-1 (c-Jun and c-Fos) expression in rat liver.
Hepatology 1998;28:744-50.
Dan Z, Popov Y, Patsenker E, Preimel D, Liu C, Wang XD, Seitz HK, Schuppan D,
Stickel F. Hepatotoxicity of alcohol-induced polar retinol metabolites involves apoptosis via loss
of mitochondrial membrane potential. FASEB J 2005;19:845-7.